Xenon Pharmaceuticals
XENE
$43.75
Share price
1.74%
Change (1 day)
7.28%
Change (1 year)
Categories
Operating Margin for Xenon Pharmaceuticals (XENE)
Operating Margin as of May 2024 (TTM): -1,327.69%
According to Xenon Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is -1,327.69%. At the end of 2022 the company had an Operating Margin of -1,327.70%.
Operating Margin history for Xenon Pharmaceuticals from 2014 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -1,327.70% | 210.3% |
| 2021 | -427.88% | 373.06% |
| 2020 | -90.45% | -85.16% |
| 2019 | -609.43% | |
| 2017 | -9,872.67% | 674.03% |
| 2016 | -1,275.49% | 1161.32% |
| 2015 | -101.12% | -320.38% |
| 2014 | 45.89% | 4.33% |
| 2013 | 43.98% | -246.32% |
| 2012 | -30.06% | -82.66% |
| 2011 | -173.34% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Coherus BioSciences
CHRS | -129.89% | -90.22% | 🇺🇸 USA |
 Atara Biotherapeutics ATRA | -465.01% | -64.98% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.